Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization1 6 4849 3559 66011 359--
Entreprise Value (EV)1 5 8148 6788 95210 74010 58610 443
P/E ratio 51,4x58,4x78,8x65,8x55,7x49,2x
Yield 0,76%0,62%0,46%0,54%0,61%0,69%
Capitalization / Revenue 5,06x6,41x7,23x7,64x6,91x6,44x
EV / Revenue 4,54x5,95x6,70x7,22x6,44x5,92x
EV / EBITDA 25,5x27,3x37,6x33,4x29,7x26,5x
Price to Book 5,01x6,69x6,75x7,15x6,54x6,02x
Nbr of stocks (in thousands) 89 44189 44189 44189 441--
Reference price (EUR) 72,5105108127127127
Last update 12/07/201812/06/201912/12/202001/19/202101/19/202101/19/2021
1 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales1 1 2811 4591 3351 4871 6441 764
EBITDA1 228318238321356394
Operating profit (EBIT)1 197235178255301340
Operating Margin 15,3%16,1%13,3%17,2%18,3%19,3%
Pre-Tax Profit (EBT)1 179230179241276331
Net income1 126160122174200230
Net margin 9,87%10,9%9,16%11,7%12,1%13,0%
EPS2 1,411,791,371,932,282,58
Dividend per Share2 0,550,650,500,690,780,88
Last update 12/07/201812/06/201912/12/202001/19/202101/19/202101/19/2021
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 670678707619773916
Leverage (Debt / EBITDA) -2,93x-2,13x-2,97x-1,92x-2,17x-2,33x
Free Cash Flow1 171237134134150178
ROE (Net Profit / Equities) 10,1%11,9%8,65%12,3%12,8%13,1%
Shareholders' equity1 1 2551 3461 4151 4071 5621 753
ROA (Net Profit / Asset) 7,70%8,67%6,07%8,37%9,17%10,4%
Assets1 1 6421 8422 0162 0742 1792 199
Book Value Per Share2 14,515,616,017,819,421,1
Cash Flow per Share2 2,092,462,002,442,903,19
Capex1 16,520,345,041,141,150,7
Capex / Sales 1,29%1,39%3,37%2,76%2,50%2,88%
Last update 12/07/201812/06/201912/12/202001/19/202101/19/202101/19/2021
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (EUR)
11 358 952 390
Capitalization (USD)
13 768 427 139
Net sales (EUR)
1 335 452 000
Net sales (USD)
1 618 594 533
Number of employees
3 290
Sales / Employee (EUR)
405 912
Sales / Employee (USD)
491 974
Free-Float
40,9%
Free-Float capitalization (EUR)
4 646 811 890
Free-Float capitalization (USD)
5 632 499 261
Avg. Exchange 20 sessions (EUR)
11 924 233
Avg. Exchange 20 sessions (USD)
14 452 409
Average Daily Capital Traded
0,10%
EPS & Dividend